BioSpace Movers & Shakers, Nov. 6
The Pharma Data
NOVEMBER 5, 2020
Horizon Therapeutics – Karin Rosén joined Ireland-based Horizon Therapeutics as executive vice president, research and development and chief scientific officer. X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Prior to Horizon, she was senior vice president, U.S. medical affairs at GlaxoSmithKline.
40 
Let's personalize your content